Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy?
作者信息
Wagner Bradley G, Kahn James S, Blower Sally
出版信息
AIDS. 2010 Mar 13;24(5):775-6. doi: 10.1097/QAD.0b013e3283366782.
Abstract
摘要
相似文献
1
Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy?我们应该通过采用“检测与治疗”策略来消除艾滋病毒流行吗？
AIDS. 2010 Mar 13;24(5):775-6. doi: 10.1097/QAD.0b013e3283366782.
2
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.审视在高度流行地区通过“检测即治疗”实现艾滋病消除的前景。
AIDS. 2010 Mar 13;24(5):729-35. doi: 10.1097/QAD.0b013e32833433fe.
3
The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.美国扩大艾滋病毒筛查和抗逆转录病毒治疗的成本效益和人群结果。
Ann Intern Med. 2010 Dec 21;153(12):778-89. doi: 10.7326/0003-4819-153-12-201012210-00004.
4
Scaling Up Human Immunodeficiency Virus Screening and Antiretroviral Therapy Among Men Who Have Sex With Men to Achieve the 90-90-90 Targets in China.在中国，扩大男男性行为人群中的人类免疫缺陷病毒筛查和抗逆转录病毒治疗，以实现 90-90-90 目标。
Sex Transm Dis. 2018 May;45(5):343-349. doi: 10.1097/OLQ.0000000000000744.
5
Cost-effectiveness analysis of 'test and treat' policy for antiretroviral therapy among heterosexual HIV population in India.印度异性恋 HIV 人群中“检测即治疗”抗逆转录病毒治疗策略的成本效益分析。
Indian J Med Res. 2022 Jun;156(6):705-714. doi: 10.4103/ijmr.IJMR_806_20.
6
Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.南非生物医学艾滋病干预措施组合：成本效益分析。
J Gen Intern Med. 2013 Oct;28(10):1294-301. doi: 10.1007/s11606-013-2417-1. Epub 2013 Apr 16.
7
Age-targeted HIV treatment and primary prevention as a 'ring fence' to efficiently interrupt the age patterns of transmission in generalized epidemic settings in South Africa.以年龄为目标的艾滋病毒治疗和一级预防作为一种“隔离带”，以有效中断南非广泛流行环境下的年龄传播模式。
Int Health. 2016 Jul;8(4):277-85. doi: 10.1093/inthealth/ihw010. Epub 2016 Mar 23.
8
HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis.美国通过第四代免疫测定法或核酸扩增试验进行 HIV 筛查的成本效益分析。
PLoS One. 2011;6(11):e27625. doi: 10.1371/journal.pone.0027625. Epub 2011 Nov 16.
9
Assessing characteristics of hidden epidemics to design the most efficient HIV testing strategies.评估隐匿性流行病的特征以设计最有效的艾滋病毒检测策略。
AIDS. 2014 Jul 31;28(12):1831-3. doi: 10.1097/QAD.0000000000000271.
10
Cost-effectiveness of voluntary HIV screening in Russia.俄罗斯自愿进行艾滋病毒筛查的成本效益
Int J STD AIDS. 2009 Jan;20(1):46-51. doi: 10.1258/ijsa.2008.008128.
引用本文的文献
1
Re-engagement and retention in HIV care after preventive default tracking in a cohort of HIV-infected patients in rural Malawi: A mixed-methods study.马拉维农村地区一组艾滋病毒感染患者预防性违约追踪后重新参与和持续接受艾滋病毒治疗：一项混合方法研究
PLOS Glob Public Health. 2024 Feb 21;4(2):e0002437. doi: 10.1371/journal.pgph.0002437. eCollection 2024.
2
HIV prevalence among men who have sex with men in Brazil: results of the 2nd national survey using respondent-driven sampling.巴西男男性行为者中的艾滋病毒流行率：第二次采用应答者驱动抽样的全国性调查结果。
Medicine (Baltimore). 2018 May;97(1S Suppl 1):S9-S15. doi: 10.1097/MD.0000000000010573.
3
Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.使用联合预防措施能否消除南非异性传播的艾滋病疫情？一项模型分析。
Am J Epidemiol. 2016 Aug 1;184(3):239-48. doi: 10.1093/aje/kwv344. Epub 2016 Jul 13.
4
Evaluating the Impact of Test-and-Treat on the HIV Epidemic among MSM in China Using a Mathematical Model.使用数学模型评估检测与治疗对中国男男性行为者中艾滋病毒流行的影响。
PLoS One. 2015 Jun 3;10(6):e0126893. doi: 10.1371/journal.pone.0126893. eCollection 2015.
5
HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.HPTN 071（PopART）：一项评估包含普遍检测和治疗的艾滋病综合预防干预对人群影响的整群随机试验的原理和设计 - 一项整群随机试验的研究方案。
Trials. 2014 Feb 13;15:57. doi: 10.1186/1745-6215-15-57.
6
Are Low- and Middle-Income Countries Repeating Mistakes Made by High-Income Countries in the Control of HIV for Men who have Sex with Men?低收入和中等收入国家是否在重复高收入国家在控制男男性行为者感染艾滋病毒方面所犯的错误？
J AIDS Clin Res. 2012;Suppl 4:e001. doi: 10.4172/2155-6113.S4-e001.
7
Massive benefits of antiretroviral therapy in Africa.抗逆转录病毒疗法在非洲带来的巨大益处。
J Infect Dis. 2014 Feb 15;209(4):483-5. doi: 10.1093/infdis/jit586. Epub 2013 Dec 3.
8
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study.通过扩大获得抗逆转录病毒疗法的机会来消除南非的艾滋病毒：模型比较研究。
PLoS Med. 2013 Oct;10(10):e1001534. doi: 10.1371/journal.pmed.1001534. Epub 2013 Oct 22.
9
Balancing efficiency, equity and feasibility of HIV treatment in South Africa - development of programmatic guidance.在南非平衡艾滋病毒治疗的效率、公平性和可行性——制定规划指导原则。
Cost Eff Resour Alloc. 2013 Oct 9;11(1):26. doi: 10.1186/1478-7547-11-26.
10
Prospects of elimination of HIV with test-and-treat strategy.以检测和治疗策略消除艾滋病毒的前景。
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15538-43. doi: 10.1073/pnas.1301801110. Epub 2013 Sep 5.
本文引用的文献
1
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.审视在高度流行地区通过“检测即治疗”实现艾滋病消除的前景。
AIDS. 2010 Mar 13;24(5):729-35. doi: 10.1097/QAD.0b013e32833433fe.
2
When to start antiretroviral therapy in resource-limited settings.在资源有限的环境中何时开始抗逆转录病毒治疗。
Ann Intern Med. 2009 Aug 4;151(3):157-66. doi: 10.7326/0003-4819-151-3-200908040-00138. Epub 2009 Jul 20.
3
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.未患艾滋病的HIV-1感染患者开始抗逆转录病毒治疗的时机：18项HIV队列研究的协作分析
Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8.
4
Effect of early versus deferred antiretroviral therapy for HIV on survival.早期与延迟抗逆转录病毒疗法对HIV感染者生存的影响。
N Engl J Med. 2009 Apr 30;360(18):1815-26. doi: 10.1056/NEJMoa0807252. Epub 2009 Apr 1.
5
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.将普遍自愿艾滋病毒检测与立即进行抗逆转录病毒治疗作为消除艾滋病毒传播的策略：一个数学模型
Lancet. 2009 Jan 3;373(9657):48-57. doi: 10.1016/S0140-6736(08)61697-9. Epub 2008 Nov 27.
6
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.在SMART研究中，未接受过抗逆转录病毒治疗（ART）的参与者以及基线时未接受ART治疗的参与者的主要临床结局。
J Infect Dis. 2008 Apr 15;197(8):1133-44. doi: 10.1086/586713.
7
Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.撒哈拉以南非洲地区抗逆转录病毒治疗项目中的结核病负担：对治疗结果的影响及对结核病控制的意义
AIDS. 2006 Aug 1;20(12):1605-12. doi: 10.1097/01.aids.0000238406.93249.cd.
8
Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?联合抗逆转录病毒疗法的广泛使用能否根除艾滋病流行？
Lancet Infect Dis. 2002 Aug;2(8):487-93. doi: 10.1016/s1473-3099(02)00346-8.
9
A tale of two futures: HIV and antiretroviral therapy in San Francisco.两种未来的故事：旧金山的艾滋病毒与抗逆转录病毒疗法
Science. 2000 Jan 28;287(5453):650-4. doi: 10.1126/science.287.5453.650.
Zotero 插件